Much has been written about the pharmaceutical industry’s R&D-productivity challenge during the past decade: the decline in new-drug approvals has…
Super UserNovember 18, 2013
QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced an agreement with Eli Lilly and Company (NYSE: LLY) to develop…
Super UserNovember 18, 2013
We’ve heard a lot this year about the IPO boom for biotech companies. Even after a few high-profile blowups (Ariad,…
Super UserNovember 18, 2013
AstraZeneca (AZ) has strengthened its research team by appointing leading academic Dr Yong-Jun Liu as head of research at its…
Super UserNovember 18, 2013
A Cambridge company developing new drugs focused around DNA damage and genetically defined cancers has attracted investment from another pharma…
Super UserNovember 18, 2013
Apply Now to be a Presenting Company at Bio€quity Europe 2014Now celebrating its 15th meeting, Bio€quity Europe is the premier…
Super UserNovember 18, 2013
Last week, the nation’s leading heart organizations released a sweeping new set of guidelines for lowering cholesterol, along with an…
Super UserNovember 18, 2013
A patient with abdominal pain dies from a ruptured appendix after a doctor fails to do a complete physical exam.…
Super UserNovember 18, 2013
IBM has made its Watson cognitive computing technology available as a cloud-based app development platform, and healthcare vendors are already…
Super UserNovember 18, 2013